Document is current
Any future updates will be listed below
-
Authors
Liu, Yifan
Sun, Yansha
Wang, Peng
Li, Songling
Dong, Yiwei
Zhou, Min
Shi, Bizhi
Jiang, Hua
Sun, Ruixin https://orcid.org/0000-0002-2096-8946
Li, Zonghai
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82073358, 82073359, 82272920)
Shanghai Collaborative Innovation Center for Translational Medicine (TM202006)
- License Information
-
More Information
Article History
Received: 10 November 2022
Accepted: 25 March 2023
First Online: 12 April 2023
Declarations
:
: The animal study was reviewed and approved by Experiment Animal Care Commission of Shanghai Cancer Institute. Written informed consent was obtained from the owners for the participation of their animals in this study.
: All authors have approved the manuscript for submission.
: Dr. Hua Jiang and Dr. Zonghai Li has ownership interests of CAR-T cells relating to this work and is a stockholder of CARsgen Therapeutics, Inc. The other authors declare that they have no conflicts of interest.
